Aphios Pharma

Growth Stage

Inspired by Nature, Enabled by Science

Analytics

Raised to Date: Raised: $110,751

Funding History

Aggregate Commitments $

Platform

Wefunder

Start Date

10/04/2021

Close Date

02/09/2022

Min. Goal

$50,000

Max. Goal

$1,000,000

Min. Investment

$250

Security Type

SAFE

Funding Type

RegCF

Series

Seed

Valuation Cap

$71,000,000

Discount Rate

Rolling Commitments $

Status

Active

Reporting Date

10/17/2021

Days Remaining

115

% of Min. Goal

222%

% of Max. Goal

11%

Likelihood of Max
likely

Avg. Daily Raise

$8,519

Momentum

Logos provided by Clearbit

Location

Woburn, Massachusetts

Industry

Healthcare & Pharmaceuticals

Tech Sector

Biotech

Distribution Model

B2B2C

Margin

High

Capital Intensity

High

Business Type

Growth

SEC Filing

Company Website

Aphios Pharma, with a valuation of $71 million, is raising funds on Wefunder. The company is developing cannabis-based therapeutics for pain, anxiety, opioid use disorder, and multiple sclerosis. The green biotech company is developing the technology for sustained release of nano encapsulated cannabinoids for chronic medical needs. Aphios Pharma has received grants from the National Cancer Institute, NCCIH, and National Institute of Drug Abuse and has spent millions of dollars on drug manufacturing and drug delivery technologies. Trevor P. Castor founded Aphios Pharma in July 2018. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $1,000,000. The campaign proceeds will be used for marketing, R&D, and G&A expenses.

Summary Profit and Loss Statement

	Most Recent Year	Prior Year
Revenue	$0	$0
COGS	$0	$0
Tax	$0	$0


Net Income	$-15,935	$-1,976

Summary Balance Sheet

	Most Recent Year	Prior Year
Cash	$1,386	$1,524
Accounts Receivable	$25,915	$41,712
Total Assets	$27,301	$43,236
Short-Term Debt	$0	$0
Long-Term Debt	$0	$0
Total Liabilities	$0	$0

Financials as of: 10/04/2021

Raise History

Offering Name	Close Date	Platform	Valuation/Cap	Total Raised	Security Type	Status	Reg Type
Aphios Pharma	02/09/2022	Wefunder	$71,000,000	$110,751	SAFE	Active	RegCF
Aphios Pharma	01/31/2019	Netcapital	$101,070,000	$48,152	Equity - Common	Funded	RegCF

Pay Monthly

Annually (Save 17%)

: $8.33 /month
billed annually; Free portfolio tracking. Limited reports and filters.; Plan Includes:; Everything in Free, plus; Advanced company search ( limited filters); Founder profiles and exclusive webinars; 2 Analyst Reports per month; Get Starter Annual Get Starter Monthly

: $25 /month
billed annually; Unlimited analyst reports and market analytics.; Plan Includes:; Everything in Starter, plus; Full access to all Analyst Reports; Filter on Staff Picks (e.g. Top Deal, Deal to Watch, etc.); Market Analytics; Get Pro Annual Get Pro Monthly

: $41.67 /month
billed annually; Full site access including Merlin ratings.; Plan Includes:; Everything in Pro, plus; Search and filter companies by Merlin ratings; Company specific Merlin rating and risk assessment; Get Merlin Annual Get Merlin Monthly